A Systematic Review of Treatments for Anxiety in Youth with Autism Spectrum Disorders

Journal of Autism and Developmental Disorders

Volumn 44, Issue 12, 2014, Pages 3215-3229

  Vasa, Roma A ^a,b   Carroll, Laura M ^c   Nozzolillo, Alixandra A ^d   Mahajan, Rajneesh ^a,b   Mazurek, Micah O ^e,f   Bennett, Amanda E ^g   Wink, Logan K ^h   Bernal, Maria Pilar ^i,j  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF MISSOURI   (United States)

^f University of Missouri   (United States)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j KAISER PERMANENTE MEDICAL CENTER   (United States)

more..

Author keywords

Adolescents; Anxiety; Autism spectrum disorders; Children; Treatments

Indexed keywords

CITALOPRAM;

ADOLESCENT; ANXIETY; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; HUMAN; PROCEDURES; PSYCHOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ANXIETY; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CITALOPRAM; CLINICAL TRIALS AS TOPIC; COGNITIVE THERAPY; HUMANS; TREATMENT OUTCOME;

EID: 84930917860     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-014-2184-9     Document Type: Article

References (68)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: American Psychiatric Association.
2. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
3. Birmaher, B., Brent, D. A., Chiappetta, L., Bridge, J., Monga, S., & Baugher, M. (1999). Psychometric properties of the screen for child anxiety related emotional disorders (SCARED): A replication study. Journal of the American Academy of Child and Adolescent Psychiatry,38(10), 1230–1236.
4. Bradley, E. A., Summers, J. A., Wood, H. L., & Bryson, S. E. (2004). Comparing rates of psychiatric and behavior disorders in adolescents and young adults with severe intellectual disability with and without autism. Journal of Autism and Developmental Disorders,34(2), 151–161.
5. Buitelaar, J. K., van der Gaag, R. J., & van der Hoeven, J. (1998). Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: Results of an open-label study. The Journal of Clinical Psychiatry,59(2), 56.
6. Busner, J., Targum, S. D., & Miller, D. S. (2009). The clinical global impressions scale: Errors in understanding and use. Comprehensive Psychiatry,50(3), 257–262.
7. Centers for Disease Control and Prevention. (2012). Prevalence of autism spectrum disorders—Autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill Summ,61(3), 1–19.
8. Chalfant, A. M., Rapee, R., & Carroll, L. (2007). Treating anxiety disorders in children with high functioning autism spectrum disorders: A controlled trial. Journal of Autism and Developmental Disorders,37(10), 1842.
9. Choudhury, M. S., Pimentel, S. S., & Kendall, P. C. (2003). Childhood anxiety disorders: Parent-child (dis) agreement using a structured interview for the DSM-IV. Journal of the American Academy of Child and Adolescent Psychiatry,42(8), 957–964.
10. Comer, J. S., & Kendall, P. C. (2004). A symptom-level examination of parent–child agreement in the diagnosis of anxious youths. Journal of the American Academy of Child and Adolescent Psychiatry,43(7), 878–886.
11. Costello, E. J., Egger, H. L., & Angold, A. (2005). The developmental epidemiology of anxiety disorders: Phenomenology, prevalence, and comorbidity. Child and Adolescent Psychiatric Clinics of North America,14(4), 631–648., vii.
12. Couturier, J. L., & Nicolson, R. (2002). A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology,12(3), 243–248.
13. Cunningham, J. A., Kypri, K., & McCambridge, J. (2013). Exploratory randomized controlled trial evaluating the impact of a waiting list control design. BMC Medical Research Methodology,13(1), 150.
14. Danial, J. T., & Wood, J. J. (2013). Cognitive behavioral therapy for children with autism: Review and considerations for future research. Journal of Developmental and Behavioral Pediatrics,34(9), 702–715.
15. Dekker, M. C., & Koot, H. M. (2003). DSM-IV disorders in children with borderline to moderate intellectual disability. I: Prevalence and impact. Journal of the American Academy of Child and Adolescent Psychiatry,42(8), 915.
16. Drahota, A., Wood, J. J., Sze, K. M., & Van Dyke, M. (2011). Effects of cognitive behavioral therapy on daily living skills in children with high-functioning autism and concurrent anxiety disorders. Journal of Autism and Developmental Disorders,41(3), 257–265.
17. Edelson, S. M., Edelson, M. G., Kerr, D. C. R., & Grandin, T. (1999). Behavioral and physiological effects of deep pressure on children with autism: A pilot study evaluating the efficacy of grandin’s hug machine. American Journal of Occupational Therapy,53(2), 145–152.
18. Evans, D. W., Canavera, K., Kleinpeter, F. L., Maccubbin, E., & Taga, K. (2005). The fears, phobias and anxieties of children with autism spectrum disorders and down syndrome: Comparisons with developmentally and chronologically age matched children. Child Psychiatry and Human Development,36(1), 3–26.
19. Farrugia, S., & Hudson, J. (2006). Anxiety in adolescents with Asperger syndrome: Negative thoughts, behavioral problems, and life interference. Focus on Autism and Other Developmental Disabilities,21(1), 25–35.
20. Forkmann, T., Scherer, A., Boecker, M., Pawelzik, M., Jostes, R., & Gauggel, S. (2011). The clinical global impression scale and the influence of patient or staff perspective on outcome. BMC Psychiatry,11(1), 83.
21. Gau, S. S., Ni, H., Shang, C., Soong, W., Wu, Y., Lin, L., et al. (2010). Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder. Australian and New Zealand Journal of Psychiatry,44(2), 135–143.
22. Gillott, A., Furniss, F., & Walter, A. (2001). Anxiety in high-functioning children with autism. Autism: The International Journal of Research and Practice,5(3), 277–286.
23. Guy, W. (1976). Clinical global impression scale. The ECDEU Assessment Manual for Psychopharmacology-Revised. Volume DHEW Publ no ADM,76(338), 218–222.
24. Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., et al. (2008). Rating quality of evidence and strength of recommendations: GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal,336(7650), 924.
25. Hsia, Y., Wong, A. Y., Murphy, D. G., Simonoff, E., Buitelaar, J. K., & Wong, I. C. (2014). Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): A multinational study. Psychopharmacology, 231(6), 999–1009.
26. Jarusiewicz, B. (2002). Efficacy of neurofeedback for children in the autistic spectrum: A pilot study. Journal of Neurotherapy,6(4), 39–49.
27. Kim, J. A., Szatmari, P., Bryson, S. E., Streiner, D. L., & Wilson, F. J. (2000). The prevalence of anxiety and mood problems among children with autism and Asperger syndrome. Autism,4(2), 117–132.
28. King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., et al. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives of General Psychiatry,66(6), 583.
29. Lang, R., Regester, A., Lauderdale, S., Ashbaugh, K., & Haring, A. (2010). Treatment of anxiety in autism spectrum disorders using cognitive behaviour therapy: A systematic review. Developmental Neurorehabilitation,13(1), 53–63.
30. Lecavalier, L., Wood, J. J., Halladay, A. K., Jones, N. E., Aman, M. G., Cook, E. H., et al. (2013). Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder. Journal of Autism and Developmental Disorders, 44(5), 1128–1143.
31. Lopata, C., Toomey, J. A., Fox, J. D., Volker, M. A., Chow, S. Y., Thomeer, M. L., et al. (2010). Anxiety and depression in children with HFASDs: Symptom levels and source differences. Journal of Abnormal Child Psychology,38(6), 765–776.
32. Lord, C., Rutter, M., DiLavore, P. C., & Risi, S. (2002). Autism diagnostic observation schedule. Los Angeles: Western Psychological Services.
33. Losh, M., & Capps, L. (2006). Understanding of emotional experience in autism: Insights from the personal accounts of high-functioning children with autism. Developmental Psychology,42(5), 809.
34. MacNeil, B. M., Lopes, V. A., & Minnes, P. M. (2009). Anxiety in children and adolescents with autism spectrum disorders. Research in Autism Spectrum Disorders,3(1), 1–21.
35. March, J. S., Conners, C., Arnold, G., Epstein, J., Parker, J., Hinshaw, S., et al. (1999). The multidimensional anxiety scale for children (MASC): Confirmatory factor analysis in a pediatric ADHD sample. Journal of Attention Disorders,3(2), 85–89.
36. Martin, A., Koenig, K., Anderson, G. M., & Scahill, L. (2003). Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study. Journal of Autism and Developmental Disorders,33(1), 77–85.
37. Martin, A., Scahill, L., & Kratochvil, C. (2010). Pediatric psychopharmacology (2nd ed.). Oxford: Oxford University Press.
38. McNally, R. H., Lincoln, A. J., Brown, M. Z., & Chavira, D. A. (2013). The coping cat program for children with anxiety and autism spectrum disorder: A pilot randomized controlled trial. Journal of Autism and Developmental Disorders,43(1), 57–67.
39. Merikangas, K. R., He, J., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L., et al. (2010). Lifetime prevalence of mental disorders in US adolescents: Results from the national comorbidity survey replication-adolescent supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry,49(10), 980–989.
40. Mohr, D. C., Spring, B., Freedland, K. E., Beckner, V., Arean, P., Hollon, S. D., et al. (2009). The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychotherapy and Psychosomatics,78(5), 275–284.
41. Moree, B. N., & Davis, T. E, I. I. I. (2010). Cognitive-behavioral therapy for anxiety in children diagnosed with autism spectrum disorders: Modification trends. Research in Autism Spectrum Disorders,4(3), 346–354.
42. Nadeau, J., Sulkowski, M. L., Ung, D., Wood, J. J., Lewin, A. B., Murphy, T. K., et al. (2011). Treatment of comorbid anxiety and autism spectrum disorders. Neuropsychiatry,1(6), 567–578.
43. Namerow, L. B., Thomas, P., Bostic, J. Q., Prince, J., & Monuteaux, M. C. (2003). Use of citalopram in pervasive developmental disorders. Journal of Developmental and Behavioral Pediatrics,24(2), 104–108.
44. Nauta, M. H., Scholing, A., Rapee, R. M., Abbott, M., Spence, S. H., & Waters, A. (2004). A parent-report measure of children’s anxiety: Psychometric properties and comparison with child-report in a clinic and normal sample. Behaviour Research and Therapy,42(7), 813–839.
45. Ozsivadjian, A., Hibberd, C., & Hollocks, M. J. (2014). Brief report: The use of self-report measures in young people with autism spectrum disorder to access symptoms of anxiety, depression and negative thoughts. Journal of Autism and Developmental Disorders,44(4), 969–974.
46. Pine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998). The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Archives of General Psychiatry,55(1), 56.
47. Reaven, J., Blakeley-Smith, A., Culhane-Shelburne, K., & Hepburn, S. (2012). Group cognitive behavior therapy for children with high-functioning autism spectrum disorders and anxiety: A randomized trial. Journal of Child Psychology and Psychiatry,53(4), 410–419.
48. Reaven, J. A., Blakeley-Smith, A., Nichols, S., Dasari, M., Flanigan, E., & Hepburn, S. (2009). Cognitive-behavioral group treatment for anxiety symptoms in children with high-functioning autism spectrum disorders a pilot study. Focus on Autism and Other Developmental Disabilities,24(1), 27–37.
49. Reinblatt, S. P., DosReis, S., Walkup, J. T., & Riddle, M. A. (2009). Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents. Journal of Child and Adolescent Psychopharmacology,19(2), 119–126.
50. Reynolds, C. R., & Richmond, B. O. (1978). What I think and feel: A revised measure of children’s manifest anxiety. Journal of Abnormal Child Psychology,6(2), 271–280.
51. Rudy, B. M., Lewin, A. B., & Storch, E. A. (2013). Managing anxiety comorbidity in youth with autism spectrum disorders. Neuropsychiatry,3(4), 411–421.
52. RUPP Anxiety Study Group. (2002). The pediatric anxiety rating scale (PARS): Development and psychometric properties. Journal of the American Academy of Child and Adolescent Psychiatry,41(9), 1061–1069.
53. Safer, D. L., & Hugo, E. M. (2006). Designing a control for a behavioral group therapy. Behavior Therapy,37(2), 120–130.
54. Silverman, W., & Albano, A. (1996). Anxiety disorders interview schedule for children for DSM-IV: (Child and parent versions). San Antonio, TX: Psychological Corporation/Graywind.
55. Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child and Adolescent Psychiatry,47(8), 921.
56. Sofronoff, K., Attwood, T., & Hinton, S. (2005). A randomised controlled trial of a CBT intervention for anxiety in children with asperger syndrome. Journal of Child Psychology and Psychiatry and Allied Disciplines,46(11), 1152–1160.
57. Spence, S. H. (1998). A measure of anxiety symptoms among children. Behaviour Research and Therapy,36(5), 545–566.
58. Storch, E. A., Arnold, E. B., Lewin, A. B., Nadeau, J. M., Jones, A. M., De Nadai, A. S., et al. (2013). The effect of cognitive-behavioral therapy versus treatment as usual for anxiety in children with autism spectrum disorders: A randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry,52(2), 132–142.
59. Sukhodolsky, D. G., Bloch, M. H., Panza, K. E., & Reichow, B. (2013). Cognitive-behavioral therapy for anxiety in children with high-functioning autism: A meta-analysis. Pediatrics,132(5), e1341–e1350.
60. Sukhodolsky, D. G., Scahill, L., Gadow, K. D., Arnold, L. E., Aman, M. G., McDougle, C. J., et al. (2008). Parent-rated anxiety symptoms in children with pervasive developmental disorders: Frequency and association with core autism symptoms and cognitive functioning. Journal of Abnormal Child Psychology,36(1), 117.
61. Sung, M., Ooi, Y. P., Goh, T. J., Pathy, P., Fung, D. S., Ang, R. P., et al. (2011). Effects of cognitive-behavioral therapy on anxiety in children with autism spectrum disorders: A randomized controlled trial. Child Psychiatry and Human Development,42(6), 634–649.
62. US Preventive Services Task Force Procedure Manual. AHRQ Publication No. 08-05118-EF, July 2008. http://www.uspreventiveservicestaskforce.org/uspstf08/methods/procmanual.htm.
63. van Steensel, Francisca J. A., Bögels, S. M., & Perrin, S. (2011). Anxiety disorders in children and adolescents with autistic spectrum disorders: A meta-analysis. Clinical Child and Family Psychology Review,14(3), 302–317.
64. Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine,359(26), 2753–2766.
65. White, S. W., Ollendick, T., Albano, A. M., Oswald, D., Johnson, C., Southam-Gerow, M., et al. (2013). Randomized controlled trial: Multimodal anxiety and social skill intervention for adolescents with autism spectrum disorder. Journal of Autism and Developmental Disorders,43(2), 382–394.
66. White, S. W., Oswald, D., Ollendick, T., & Scahill, L. (2009). Anxiety in children and adolescents with autism spectrum disorders. Clinical Psychology Review,29(3), 216–229.
67. Wigham, S., & McConachie, H. (2014). Systematic review of the properties of tools used to measure outcomes in anxiety intervention studies for children with autism spectrum disorders. PLoS ONE,9(1), e85268.
68. Wood, J. J., Drahota, A., Sze, K., Har, K., Chiu, A., & Langer, D. A. (2009). Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: A randomized, controlled trial. Journal of Child Psychology and Psychiatry,50(3), 224–234.